Last reviewed · How we verify
NCT04558073: HEIDI-BP-HW
Evaluation of Two Eating Disorders Prevention Interventions in At-Risk Female Students With Body Dissatisfaction
NA trial testing Body Project (BP) in Body Dissatisfaction in 40 participants. Completed in 12 July 2022.
30 May 2022
Quick facts
| Lead sponsor | School of Health Sciences Geneva |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 40 |
| Start date | 1 January 2021 |
| Primary completion | 30 May 2022 |
| Estimated completion | 12 July 2022 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- Body Project (BP)
- Healthy Weight Program (HW)
Conditions studied
- Body Dissatisfaction — all drugs for Body Dissatisfaction →
Sponsor
School of Health Sciences Geneva
Who can join
Adults 18 to 25, female only, with Body Dissatisfaction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Eating disorders are psychopathologies with serious repercussions on the somatic, psychological and social level. Currently available treatments are unfortunately for now not fully efficient, therefore researchers have recommended to develop prevention initiatives. Until now, no study has been carried out in Switzerland to evaluate the efficacy of an intervention for the prevention of eating disorders. The goal of the present study is to evaluate two eating disorders prevention intervention that have been largely validated in the US, called the Body Project (BP) and the Healthy Weight Program (HW). Both interventions target body dissatisfaction, which is a well-identified risk factor of eating disorders. They will be compared to a one-month waiting list. Because of the pandemic situation due to the Severe Acute Respiratory Syndrome coronavirus (COVID-19), both interventions will be delivered virtually via a collaborative platform. The sessions will be recorded to carry out a quality control. To compare the BP and HW interventions to a waiting list, a three-arm randomized controlled study will be carried out, including female students from French-speaking Switzerland. Recruitment will include 90 participants. Participants will be randomly assigned to one of the three arms of the study. They will be evaluated before (T0) and after (T1) the interventions or the waiting list. Following the interventions, the participants will have one month of follow-up before a final evaluation (T2). Participants on the waiting list will receive the BP following the one-month waiting period and will then be evaluated (T2). After having signed the consent form, the participant will be randomized to one of the three study arms, with a 1: 1: 1 allocation ratio. Interventions will be given in groups of six participants. Randomization will be blocked to ensure groups of equal size, and that groups of six participants for each arm are regularly formed. The blocks will be of variable size (3, 6, 9) to protect the concealment. The hypotheses are as follows: 1. The two interventions BP and HW will have an effect on body dissatisfaction (primary outcome) as well as on the thin-ideal internalization, dietary restraint, negative affect, and eating disorders psychopathology (secondary outcomes), compared to the waiting list; 2. There will be no differences between the BP and the HW on the primary and secondary outcomes; 3. The effects observed thanks to the interventions will be maintained after one month of follow-up.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
A randomized controlled trial to evaluate the acceptability and effectiveness of two eating disorders prevention interventions: the HEIDI BP-HW project.
Carrard I, Cekic S, Bucher Della Torre S. · · 2023 · cited 2× · PMID 37612687 · DOI 10.1186/s12905-023-02607-6 -
A study protocol for a preliminary randomised controlled trial assessing the acceptability and effectiveness of two eating disorders prevention interventions in Switzerland: The HEIDI BP-HW project.
Carrard I, Bucher Della Torre S. · · 2021 · cited 1× · PMID 34780528 · DOI 10.1371/journal.pone.0259796
Verify or expand the search:
- PubMed search for NCT04558073
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Body Dissatisfaction
Currently open trials in the same condition.
- NCT06950905 — Contemplative Practice for Well-being and Self-Deconstruction in Women · NA · recruiting
- NCT06385457 — The Effects of Mindhelper.dk: a Self-guided Digital Mental Health Promotion Service Targeting Young People · NA · recruiting
- NCT06724796 — Yoga 4 Body Image (Y4BI): Investigating the Impact of Yoga on Body Image and Eating Behaviours · NA · recruiting
- NCT05863598 — Prevention of Eating Disorders Through Optimization of Protective Factors · NA · recruiting
Other School of Health Sciences Geneva trials
Trials by the same sponsor.
- NCT07444151 — Post-Stroke Fatigue Perception Study (ReFast) · recruiting
- NCT07439367 — Multifocal Theta-Burst Stimulation to Enhance Upper Limb Motor Recovery After Stroke (INSPIRE) · NA · recruiting
- NCT05715190 — Development and Feasibility of a Nurse-led Person-centered Education Program · NA · enrolling by invitation
- NCT05912270 — Orchestra in Class, a Novel Booster for Executive Functions and Brain Development in Young Primary School Children · NA · recruiting
- NCT04370106 — The Impact of Frequenting a Social Leg Program on Therapeutic Adherence and Venous Leg Ulcer Wound Healing Outcomes · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04558073 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by School of Health Sciences Geneva
- Last refreshed: 27 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04558073.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing